You are here

In this section, you will find various updates concerning the veterinary aspects of Equestrian Sport.

  • October 2018 - Altrenogest is used to suppress oestrus in mares, and its use for this specific purpose is allowed under FEI rules. Its use in a male horse (gelding or stallion) is not permissible.

    Earlier this year, Australian racehorses tested positive for the anabolic agents Trendione and Trenbolone following administration of Altrenogest. The investigation revealed that traces of these two substances could be found in Altrenogest products as a result of the manufacturing process in a specific factory. Following the investigation some horse sport regulatory bodies have issued a warning regarding the use of Altrenogest.

    The FEI has conferred with the Director of the FEI Central Laboratory and can confirm that, with the currently available information, it is permissible to continue to use Altrenogest product Regu-Mate Solution 2.2 mg/mL for mares as per the manufacturer’s instructions. The FEI Veterinary Department recommends that anyone using or planning to use the product on a mare should discuss this with their veterinarian. 

  • March 2018 - RESPE, the French disease outbreak report system has reported 22 venues that have been infected by Equine Herpes Virus (EHV) since January 2018. The regions of Normandy, Brittany and Loire Valley are the most affected. The outbreaks have mainly affected sport horse populations but also breeding horses and have recently caused the cancellation of some events in western France. More information from the FEI regarding this outbreak can be found here. The FEI Veterinary Department would also like to share some biosecurity measures to safeguard the horse population. 
  • For advice on the transport of FEI horses within Europe, please refer to our guidance note by clicking here.
  • Equine Infectious Anaemia Cases in Europe. Due to the recently confirmed cases of Equine Infectious Anaemia (EIA) in several parts of Europe, including Germany, the FEI wishes to inform all competitors and owners about the nature of this disease. It is important to seek veterinary advice if there is any suspicion of a horse showing signs of the disease. Within Europe, where EIA is a notifiable disease, any suspected case must be reported to the relevant government authorities.

    Equine Infectious Anaemia, also known as Swamp Fever, is a viral disease which affects horses, mules and donkeys and is most commonly spread by biting insects such as horse flies and midges. At present no treatment or effective vaccination exists for this disease. EIA is not spread from horses to people and it is therefore of no risk to human health. The presence of the disease can be indicated by a variety of tests, the most commonly known being the “Coggins Test” (AGID Test). 

    EIA does not spread quickly and is unlikely to spread widely from infected horses. While EIA may be fatal in horses, recovering animals remain lifelong carriers of the disease and will remain infectious to other animals. Therefore, in Europe infected horses must be humanely destroyed to prevent the further spread of the virus.

    Further information on EIA produced by the OIE can be found here. If you have concerns that your horse may be developing signs of EIA, or you believe it has been in contact with a horse known to have been diagnosed with EIA, you must isolate it and consult your Veterinary Adviser.
Updates from the FEI Veterinary Department
December 2018 - Permitted Treating Veterinarian Update
December 2018 - Official Veterinarian Update
July 2018 - Permitted Treating Veterinarian Update
June 2018 - Official Veterinarian Update
December 2017 - Official Veterinarian Update
December 2017 - Permitted Treating Veterinarian Update
December 2017 - Testing Veterinarian Update
December 2016 - Official Veterinarian Update
November 2016 - Official Veterinarian Update
August 2016 - Official Veterinarian Update